Atlas Trials

Alprostadil in Maculopathy Study (AIMS)

Clinical trial NCT00619229 · TERMINATED

Trial details

NCT number
NCT00619229
Sponsor
UCB Pharma
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Macular Degeneration
Start date
2006-07-01
Primary completion
2010-02-01
Enrollment
37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.